ABOUT US
OUR INITIATIVES
PUBLICATIONS
NEWS
BLOG
OUR TEAM
CONTACT US
DONATE
DONATE
ABOUT US
OUR INITIATIVES
PUBLICATIONS
NEWS
BLOG
OUR TEAM
CONTACT US
DONATE
Facebook
Twitter
Linkedin
NEWS
Updates on the IMMONC0008 Trial On Non-Small Cell Lung Cancer
View more
Dr. Karl Balabanian to Visit Armenia this October
View more
Shushan Hovsepyan Appointed as Innovation and Development Director at the Immune Oncology Research Institute
View more
IMMONC at the ASCO 2024 Annual Meeting
View more
Update on the “Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect” trial
View more
Astghik Voskanyan presented recent developments of the BPDCN International Registry at the 29th Congress of EHA
View more
OncoDaily Leukemia Conference
View more
OncoThon 2024
View more
IMMONC Team at AOC 2024
View more
CLINICAL TRIAL APPROVAL GRANTED
View more
Amalya Sargsyan has been awarded the ASCO IDEA Award
View more
CLINICAL TRIAL UPDATE
View more
IMMONC annual report for 2023
View more
Amalya Sargsyan was granted an ESO Fellowship in Milan
View more
Introducing our Research Fellow, Dr. Lusine Harutyunyan
View more
Moffitt Cancer Center joins BPDCN International Registry
View more